PCMA: DIR Legislation Would Increase Premiums, Medicare Part D Costs
February 15, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on H.R. 1038, legislation introduced by Reps....
PCMA: DIR Legislation Would Increase Premiums, Medicare Part D Costs
February 15, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on H.R. 1038, legislation introduced by Reps....
PCMA Releases New Video: “What is Drug Price Transparency?”
February 08, 2017
(Washington, D.C.) — As part of its DrugBenefitSolutions.com campaign, the Pharmaceutical Care Management Association (PCMA) today released a new video,...
PCMA Statement on New Class-Action Lawsuit Against Drug Companies
January 30, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s new class-action lawsuit against three...